However, neonatal hepatocyte-specific Dio2-KO impaired response to HFD, resulting in alteration of lipid metabolism and PPARy expression, as well as lower rate of obesity and hepatic steatosis [208]. This evidence concerns the gene DIO2 and Obesity.